Alopecia Nervous System Diseases Alopecia
Conditions
Interventions
This study consist of two phases. In the first phase, patients are approached to participate in the study. This is done when the patient has been in the Intensive Therapy Unit (ITU) for five or more d
Sponsors
Abertawe Bro Morgannwg University Health Board
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or more (no upper limit) 2. Capacity to consent to participation 3. Capacity to complete survey 4. ICU stay of five or more days 5. Survived to three months post ICU discharge
Exclusion criteria
Exclusion criteria: 1. Aged less than 18 years 2. No capacity to consent to participation 3. No capacity to complete survey 4. ICU stay of less than five days 5. Does not survive to three months post ICU discharge 6. Patients requiring chemotherapy that will potentially cause alopecia 7. Patients who suffer with any pre-existing alopecia / baldness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence and nature of patient reported alopecia in survivors of critical illness is measured using a patient reported survey at three months post ITU discharge. | — |
Secondary
| Measure | Time frame |
|---|---|
| Risk factors for alopecia in survivors of critical illness are measured using a patient record survey at three months post ITU discharge. | — |
Countries
United Kingdom, Wales
Contacts
Public ContactCeri Battle
Outcome results
None listed